Back
Vertex Pharmaceuticals Vs. Eli Lilly and Industry Stock Comparison
Sell
47
VRTX
Vertex Pharmaceuticals
Last Price:
$480.47
Seasonality Move:
4.76%
Buy
71
LLY
Eli Lilly and
Last Price:
$873.47
Seasonality Move:
3.46%
Sell
47
Vertex Pharmaceuticals (VRTX)
is a Sell
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
-
The current Vertex Pharmaceuticals [VRTX] share price is $471.76. The Score for VRTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
VRTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
-
The current Eli Lilly and [LLY] share price is $867.05. The Score for LLY is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
LLY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $471.76Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $867.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LLY is experiencing slight buying pressure.
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.48 | Buy |
Relative Strength Index (14 RSI): | 60.58 | Buy |
Chaikin Money Flow: | 1275526 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
LLY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 21.83 | Buy |
Relative Strength Index (14 RSI): | 62.14 | Buy |
Chaikin Money Flow: | -583184 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 462.9 | Buy |
20-day SMA: | 457.95 | Buy |
50-day SMA: | 439.91 | Buy |
200-day SMA: | 462.81 | Buy |
8-day EMA: | 464.05 | Buy |
20-day EMA: | 456.65 | Buy |
50-day EMA: | 449.86 | Buy |
200-day EMA: | 448.59 | Buy |
LLY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 865.69 | Buy |
20-day SMA: | 831.61 | Buy |
50-day SMA: | 800.36 | Buy |
200-day SMA: | 846.37 | Buy |
8-day EMA: | 858.26 | Buy |
20-day EMA: | 837.05 | Buy |
50-day EMA: | 817.53 | Buy |
200-day EMA: | 807.57 | Buy |
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.26 per share, an increase this year of $17.62 per share, and an increase next year of $2.27 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.38 per share, an increase next quarter of $0.20 per share, an increase this year of $10.29 per share, and an increase next year of $5.95 per share.
Vertex Pharmaceuticals Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Eli Lilly and Technical Analysis
Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
06 | 07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |